Incidence of increases in pump power use and associated clinical outcomes with an axial continuous-flow ventricular assist device

J Heart Lung Transplant. 2014 Jan;33(1):105-6. doi: 10.1016/j.healun.2013.08.020. Epub 2013 Nov 14.

Authors

Robert J Steffen¹, Edward G Soltesz¹, Kimberly Miracle¹, Sangjin Lee², Maria Mountis², Nader Moazami¹

Affiliations

¹ Department of Cardiothoracic Surgery, Cleveland Clinic, Cleveland, Ohio.
² Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

PMID: 24418736
DOI: 10.1016/j.healun.2013.08.020

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Biomarkers / blood
Equipment Design
Heart Failure / therapy*
Heart-Assist Devices / adverse effects*
Heart-Assist Devices / classification*
Hemolysis
Humans
Incidence
L-Lactate Dehydrogenase / blood
Retrospective Studies
Thrombosis / epidemiology*
Treatment Outcome
Ventricular Dysfunction, Left / therapy*

Substances

Biomarkers
L-Lactate Dehydrogenase